Tobira Therapeutics (TBRA)
42.09 +0.27 (+0.65%) 10/31/16 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
for Mon, Oct 31st, 2016
Results
download Want to compare other data? Select Fields| Symbol | TBRA | GRAL | NTLA | ||
| Company | Tobira Therapeutics | Grail Inc | Intellia Thera CS | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 41.83 | 22.91 | 6.74 | ||
| High | 42.33 | 23.43 | 7.44 | ||
| Low | 40.39 | 22.30 | 6.65 | ||
| Last | 42.09 | 23.26 | 7.41 | ||
| Change | +0.27 | +0.51 | +0.64 | ||
| % Change | +0.65% | +2.24% | +9.45% | ||
| Volume | 521,800 | 1,026,600 | 2,357,100 | ||
| 20-Day Average Volume | 230,795 | 1,174,990 | 3,892,740 | ||
| Previous Close | 41.82 | 22.75 | 6.77 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 40.68 | 26.54 | 7.86 | ||
| 20-Day Raw Stochastic | 91.81% | 21.61% | 37.84% | ||
| 20-Day Relative Strength | 87.55% | 42.97% | 42.51% | ||
| Weighted Alpha | +35.00 | -28.40 | -72.62 | ||
| Today's Opinion | N/A | 24% Buy | 100% Sell | ||
| Previous Opinion | N/A | 24% Buy | 100% Sell | ||
| Last Month's Opinion | N/A | 24% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.42% since 10/24/16 | +4.54% since 04/04/25 | +11.76% since 04/04/25 | ||
| Low | 40.39 on 10/31/16 | 20.44 on 04/07/25 | 5.90 on 04/07/25 | ||
| High | 42.33 on 10/31/16 | 26.20 on 04/08/25 | 7.44 on 04/11/25 | ||
| 1-Month | |||||
| %Chg | +5.91% since 09/30/16 | -23.84% since 03/11/25 | -20.32% since 03/11/25 | ||
| Low | 39.40 on 10/04/16 | 20.44 on 04/07/25 | 5.90 on 04/07/25 | ||
| High | 42.33 on 10/31/16 | 33.49 on 03/24/25 | 10.18 on 03/13/25 | ||
| 3-Month | |||||
| %Chg | +876.57% since 07/29/16 | +31.19% since 01/10/25 | -27.35% since 01/10/25 | ||
| Low | 3.76 on 08/02/16 | 16.56 on 01/16/25 | 5.90 on 04/07/25 | ||
| High | 42.33 on 10/31/16 | 63.99 on 02/18/25 | 12.84 on 02/20/25 | ||
| 6-Month | |||||
| %Chg | +434.82% since 04/29/16 | +60.52% since 10/11/24 | -60.12% since 10/11/24 | ||
| Low | 3.76 on 08/02/16 | 12.76 on 10/29/24 | 5.90 on 04/07/25 | ||
| High | 42.33 on 10/31/16 | 63.99 on 02/18/25 | 21.47 on 10/18/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 787,090 | 788,398 | 767,061 | ||
| Shares Outstanding, K | 18,820 | 33,895 | 103,517 | ||
| Annual Sales | 0 | 125,600,000 | 57,880,000 | ||
| Annual Net Income | -49,620,000 | -2,027,010,000 | -519,020,000 | ||
| Last Quarter Sales | 1,060,000 | 38,250,000 | 12,870,000 | ||
| Last Quarter Net Income | -13,340,000 | -97,070,000 | -128,900,000 | ||
| 60-Month Beta | -2.81 | N/A | 2.23 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -1.86 on 02/20/25 | -1.24 on 02/27/25 | ||
| Latest Earnings Date | 11/08/16 | 05/15/25 | 05/08/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||